Russell Tracy, Ph.D.is University Distinguished Professor of Pathology & Laboratory Medicine (PLM), and Biochemistry at the University of Vermont (UVM). Administratively, he served as Senior Associate Dean of Research and Academic Affairs of the Larner College of Medicine for over a decade. Since 1990, Dr. Tracy’s research has focused on the molecular and genetic epidemiology of coagulation, fibrinolysis and inflammation, especially the innate and adaptive immune systems and their roles in the etiology of atherosclerosisand coronary heart disease, insulin resistance and diabetes, HIV-related morbidityand mortality, and other complex diseases, as well as more broadly in the process of aging. Continuously funded by NIH since 1984, Dr. Tracy is the founding Director of the Laboratory for Clinical Biochemistry Research (LCBR) at UVM. He is involved in many molecular and genetic epidemiological studies often as a member of the Steering Committee; including the NHLBI-funded Cardiovascular Health Study (CHS), the Multi-Ethnic Study of Atherosclerosis (MESA), and Risk Underlying Rural Areas Longitudinal study (RURAL).
Recently, he has been participating in large, multi-cohort genomic studies such as the Exome Sequencing Program (ESP) and the Trans-Omics for Precision Medicine (TOPMed) program. Most recently, he became the Vice-Chair, Steering Committee of the $170M Common Funded initiative to map the Molecular Transducers of Physical Activity (MoTrPAC).
